Investigator-Initiated Studies Examine Artefill’s Use with Age-Related and HIV-Associated Facial Lipoatrophy Patients SAN DIEGO, Feb. 2 (HSMN NewsFeed) — Suneva Pharmaceutical, a privately-held aesthetic clinical device company, today announced that 2 clin…
Devices, Dermatology
Suneva Pharma, Artefill, lipoatrophy

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “2 Studies Discover Artefill(R) to Be a Long-Term Treatment Option for Facial Lipoatrophy”
Leave a Comment